Aevi Genomic Medicine, Inc. — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/235f58ff-ff17-410a-b868-c7ab57b0806d/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-31.0M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-017064 |
| FY 2017 | $-34.7M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-014238 |
| FY 2016 | $-41.9M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-013576 |
| FY 2015 | $-36.6M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-084435 |
| FY 2014 | $-18.9M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-008677 |
| FY 2013 | $-83.0M | 2000-01-27 – 2014-03-31 | evidence 0001144204-14-028382 |
| FY 2012 | $-64.5M | 2000-01-27 – 2013-03-31 | evidence 0001144204-13-027228 |
| FY 2011 | $-49.3M | 2000-01-27 – 2012-03-31 | evidence 0001144204-12-028409 |
| FY 2010 | $-3.4M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-013127 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).